Spain Accuses Novo Nordisk Of Covert Advertising For Prescription Weight-Loss Drugs

benzinga.com/news/health-care/25/06/46139132/spain-accuses-novo-nordisk-of-covert-advertising-for-prescription-weight-loss-drugs

Yellow Card Biobank, a collaboration between the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, will start investigating whether the risk of acute pancreatitis (inflamed pancreas) from GLP-1 injections for weight loss and Type 2 diabetes may be…

This story appeared on benzinga.com, 2025-06-27 13:39:16.
The Entire Business World on a Single Page. Free to Use →